Related Experiment Video
Updated: Jun 24, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
Gene therapy: the end of the rainbow?
1Department of Microbiology & Immunology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. shillite@upstate.edu
Abstract:
The increased understanding of the molecular basis of oral cancer has led to expectations that correction of the genetic defects will lead to improved treatments. Nevertheless, the first clinical trials for gene therapy of oral cancer occurred 20 years ago, and routine treatment is still not available. The major difficulty is that genes are usually delivered by virus vectors whose effects are weak and temporary. Viruses that replicate would be better, and the field includes many approaches in that direction. If any of these are effective in patients, then gene therapy will become available in the next few years. Without significant advances, however, the treatment of oral cancer by gene therapy will remain as remote as the legendary pot of gold at the end of the rainbow.
Insights
Gene therapy for oral cancer shows promise but faces challenges. Current virus vectors are temporary; replicating viruses could offer a breakthrough for effective, long-term oral cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Significant advancements in understanding oral cancer molecular genetics.
- Gene therapy holds potential for improved oral cancer treatments.
- Despite 20 years of clinical trials, routine gene therapy for oral cancer is unavailable.
Purpose of the Study:
- To review the progress and challenges in oral cancer gene therapy.
- To identify key obstacles hindering the clinical application of gene therapy for oral cancer.
- To explore future directions for effective oral cancer gene therapy.
Main Methods:
- Review of existing literature on oral cancer gene therapy clinical trials.
- Analysis of viral vector limitations in gene delivery for cancer treatment.
- Examination of research into replicating viral vectors for enhanced gene therapy efficacy.
Main Results:
- Current gene delivery methods using non-replicating virus vectors have shown weak and temporary effects.
- The development of replicating viruses presents a promising avenue for more potent and sustained gene therapy.
- Significant challenges remain in translating research findings into effective patient treatments.
Conclusions:
- Effective gene therapy for oral cancer remains a distant goal without substantial breakthroughs.
- The development of safe and effective replicating viral vectors is crucial for the future of oral cancer gene therapy.
- Continued research into advanced gene delivery systems is essential to overcome current limitations.
More Related Videos
07:43A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
Published on: July 14, 2023
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
Related Concept Videos
Gene Therapy
Gene Therapy
What is Genetic Engineering?
Microorganisms in Medicine and Therapeutics
In-vitro Mutagenesis
Pharmacogenomics: Identification of New Drug Targets